UBS Group’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.58M | Buy |
891,028
+137,870
| +18% | +$863K | ﹤0.01% | 2968 |
|
|
2025
Q1 | $4.41M | Buy |
753,158
+65,836
| +10% | +$386K | ﹤0.01% | 3062 |
|
|
2024
Q4 | $5.65M | Buy |
687,322
+665,336
| +3,026% | +$5.47M | ﹤0.01% | 2870 |
|
|
2024
Q3 | $196K | Buy |
21,986
+7,721
| +54% | +$68.8K | ﹤0.01% | 4716 |
|
|
2024
Q2 | $108K | Sell |
14,265
-22,381
| -61% | -$169K | ﹤0.01% | 4995 |
|
|
2024
Q1 | $288K | Buy |
36,646
+5,584
| +18% | +$43.8K | ﹤0.01% | 4471 |
|
|
2023
Q4 | $275K | Buy |
31,062
+30,337
| +4,184% | +$269K | ﹤0.01% | 4398 |
|
|
2023
Q3 | $6.5K | Buy |
+725
| New | +$6.5K | ﹤0.01% | 6157 |
|
|
2023
Q2 | – | Sell |
-545
| Closed | -$5.06K | – | 7793 |
|
|
2023
Q1 | $5.06K | Sell |
545
-559
| -51% | -$5.19K | ﹤0.01% | 6991 |
|
|
2022
Q4 | $11.6K | Sell |
1,104
-11,163
| -91% | -$117K | ﹤0.01% | 7188 |
|
|
2022
Q3 | $222K | Sell |
12,267
-4,053
| -25% | -$73.3K | ﹤0.01% | 3980 |
|
|
2022
Q2 | $231K | Buy |
16,320
+15,566
| +2,064% | +$220K | ﹤0.01% | 3834 |
|
|
2022
Q1 | $17K | Sell |
754
-1,893
| -72% | -$42.7K | ﹤0.01% | 6589 |
|
|
2021
Q4 | $45K | Buy |
+2,647
| New | +$45K | ﹤0.01% | 5897 |
|